While we do not have a definite mechanistic explanation for why HER2‐positive breast cancer brain metastases exhibit a greater degree of enhancement and a greater relative cerebral blood volume than HER2‐negative breast cancer brain metastases, we suspect that this may be related to increased vascular permeability and leakage of contrast from the blood–brain barrier. Here, ERBB2 is linked to breast carcinoma.